About BioVision
BioVision is a Healthcare company based in Milpitas (United States) founded in 1999, and was acquired by Abcam in August 2021. It develops assay kits, antibodies, proteins enzymes, and other research tools. The company has 65 employees. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is BIOVISION INCORPORATED. Its competitors include GenScript, OriGene and Meridian Bioscience; 2 of its 3 listed competitors have raised funding.
Company details
BioVision was founded in 1999 in Milpitas, United States, within the biotechnology sector. Products such as assay kits, antibodies, recombinant proteins, and enzymes are developed for research into apoptosis, metabolism, cell proliferation, cellular stress, cell damage, and repair. These research tools are offered and distributed to customers in more than 60 countries worldwide.
- Headquarters Milpitas, United States
- Employees 65
- Stage Acquired
- SectorsHealthcare
- Website biovision.com
- Social LinkedIn X
- Acquired by Abcam (Aug 2021)
- Legal Name Biovision Incorporated
Funding Insights of BioVision
- Total Rounds 1
All 1 funding rounds of BioVision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | Unspecified | – | – | – |
1 investors in total: 1 institutional.
Investors in BioVision
BioVision has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abcam.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biological reagents and antibodies are developed for life science research. | 1998 | abcam.com | Cambridge, United Kingdom |
Investor details for BioVision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BioVision
3 dated milestones of BioVision across 25 years, from founding to its latest funding, stage changes and deals.
- Founded BioVision is founded.
- Exit Acquired by Abcam.
- Funding First funding round.
Competitors of BioVision
BioVision has 3 listed competitors in our database, 2 of them funded. They include GenScript, OriGene and Meridian Bioscience.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | Molecular diagnostic device and kits |
Detailed competitors of BioVision
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioVision
Websites that share an audience with BioVision (biovision.com).
Websites whose visitors overlap most with BioVision. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abcam.com | 100% | 602.8K | #91,958 | View details | |
| cellsignal.com | 100% | 488.2K | #114,694 | View details | |
| caymanchem.com | 97% | 393.1K | #148,469 | View details | |
| scbt.com | 97% | 444.3K | #138,937 | View details | |
enzolifesciences.com | enzolifesciences.com | 96% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for BioVision
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as BioVision (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biovision
Complete news archive for BioVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioVision
BioVision was founded in 1999 and raised its 1st funding round 25 years after it was founded.
BioVision is headquartered in Milpitas, United States. It is registered at Milpitas, California, United States.
BioVision has 65 employees.
BioVision was founded in 1999 in Milpitas, United States, within the biotechnology sector. Products such as assay kits, antibodies, recombinant proteins, and enzymes are developed for research into apoptosis, metabolism, cell proliferation, cellular stress, cell damage, and repair. These research tools are offered and distributed to customers in more than 60 countries worldwide.
BioVision's top competitors include Meridian Bioscience, GenScript and OriGene.
BioVision has 1 investor. Key investors include Abcam.
BioVision operates through Biovision Incorporated.
Yes. BioVision was acquired by Abcam in August 2021.